B.P. Marsh Delivers Robust Half-Year Results with 9.5% Total Shareholder Return
B.P. Marsh reports 9.5% TSR in H1 2025, with NAV up 7.1% and a debt-free strategy driving dividends and buybacks.
This article covers information on B.P. Marsh & Partners PLC.
LON:BPMB.P. Marsh’s half-year: NAV climbs 7.1% and returns hit 9.5%
B.P. Marsh & Partners has delivered another tidy set of numbers for the six months to 31 July 2025. Net Asset Value (NAV – total assets minus liabilities) rose by £23.1 million to £349.5 million, with undiluted NAV per share up 7.4% to 956.1p. Add in three dividend payments and you get a Total Shareholder Return (TSR – NAV growth plus dividends) of 9.5% for the period.
What stands out is that the equity portfolio continues to do much of the heavy lifting, helped by several new investments and a profitable disposal in Australia. The Group remains debt free and has continued to return cash through both dividends and buybacks.
Key half-year numbers investors care about
| NAV | £349.5m (+7.1%) |
| NAV per share (undiluted) | 956.1p |
| NAV per share (diluted) | 909.8p |
| Profit before tax | £32.1m |
| Total Shareholder Return (H1) | 9.5% |
| Equity portfolio value | £271.5m (+12.8% adjusting for deals) |
| Cash and treasury funds (31 Jul) | £52.6m |
| Current cash (CIO commentary) | £36.5m |
| Loan book | £31.1m at 31 Jul; £36.0m at 21 Oct |
| Dividends paid YTD (FY26) | £8.0m |
| Share buybacks | £1.0m during period; £5.0m post period |
What drove the uplift in NAV
Unrealised gains on the portfolio were the headline driver, with £30.8 million of mark-ups feeding into a £32.1 million pre-tax profit. Over the past 12 months, the equity portfolio value is up 61.2% (adjusted for additions and disposals), with NAV up 38.2%.
Three new investments landed in the half, reinforcing the core strategy of backing early-stage insurance distribution and niche financial services platforms:
- iO Finance Partners – 8.0% stake for £10.0m, backing a buy-and-build in UK SME lending across SME Capital, Seneca and Provira, which together have provided £124.0m of annualised funding.
- Amiga Specialty – 49.0% equity for a nominal £49 plus a five-year £10.0m loan facility to build an international specialty underwriting agency.
- Cameron Specialty – 27.0% stake for £1.1m plus a £0.6m loan facility, focused on UK commercial property lines.
On the exit side, the Group sold Sterling Insurance in Australia for AU$6.5m (£3.1m), achieving an 8.8% internal rate of return, and rolled the proceeds into ATC, lifting its ATC stake to 27.0%.
Busy post-period deal flow keeps momentum up
Four additional investments since July show the pipeline is real and cash is being put to work:
- Gambit Re – c.8.3% preferred equity with an 8.0% preferred return, US$1.875m initially funded, supporting five profitable XPT underwriting programmes.
- XPT Producer Co – 35.0% cumulative preferred stake for US$3,500, plus up to US$12.5m of loans at SOFR + 6.5% (10% minimum) to recruit revenue-generating producers.
- Salus Capital – 35.0% cumulative preferred ordinary stake, up to £2.0m in equity and loans, focused on Professional Indemnity across broking and underwriting.
- Oneglobal Broking – £10.0m in cumulative convertible preferred shares with an 8.0% dividend. On conversion, B.P. Marsh would own 10.0% on a fully diluted basis.
Shareholder returns: dividends, buybacks and a broader register
Dividends paid so far in FY26 total £8.0m (interim £2.5m, special £3.0m, final £2.5m). The Board intends to maintain a minimum annual dividend of £5.0m for the years to 31 January 2027 and 2028.
The £2.0m buyback programme repurchased 145,000 shares for £1.0m during the period at an average 703p. Post period, a further £5.0m was deployed into buybacks. There was also a meaningful shift in the shareholder base, with a phased secondary placing by The Ardonagh Group and increased holdings by institutions including Wellington Management.
Portfolio standouts and moving parts
- Pantheon Specialty Group – now 39.0% owned after a £5.5m top up. Contributed a +21.9p per share NAV uplift in the period. Pantheon also financed a 25.0% stake in Fraction Insurance Brokers Asia, targeting the digital asset insurance niche.
- ATC Insurance Solutions – valuation £39.21m with the shareholding lifted to 27.0%. Budgeting GWP above AU$300.0m for FY26, up from c.AU$61.0m at initial investment.
- Stewart Specialty Risk Underwriting (SSRU) – strong 2025 trading, new Primary Casualty division launched, and a +25.1p per share NAV uplift.
- LEBC – first earn-out payment of £5.7m received in September 2025. Two further payments expected over 2026 and 2027.
How the market backdrop fits
Insurance rates have continued to soften in 2025, with global rates down 7.0% in H1, as capacity improves. B.P. Marsh’s response is to tilt towards specialist teams and niche underwriting and broking where execution and expertise can trump the cycle. M&A in insurance intermediaries remains busy, creating both competition and opportunity for bolt-ons and team hires across the portfolio.
A quick glossary for newer investors
- NAV – Net Asset Value, effectively the book value of the Group.
- TSR – Total Shareholder Return, combining NAV growth and dividends.
- MGA – Managing General Agent, an underwriting agency that writes insurance on behalf of insurers.
- GWP – Gross Written Premium, the total premium placed or underwritten.
My take: quality progress, with clear watchpoints
Positives:
- Consistent NAV compounding – undiluted NAV per share up to 956.1p and strong unrealised gains.
- Cash returns – £8.0m of dividends already in FY26 and an active buyback programme.
- Disciplined deployment – seven investments during and after the period, aligned with the specialist strategy.
- Debt free with substantial liquidity – £52.6m at 31 July and £36.5m available per management’s latest update.
Watchpoints:
- Softening rates – more pressure on pricing, placing a premium on niche underwriting and broking execution.
- Unrealised gains – performance leans on revaluations, so delivery at portfolio company level remains key.
- Deferred tax on US holdings – provision of £12.3m reflects gains in US LLC assets.
- Funding follow-through – several commitments and loan facilities will need disciplined drawdown and returns.
Why this matters
B.P. Marsh is sticking to its knitting – backing specialist, entrepreneurial teams in insurance distribution and adjacent finance niches. The numbers show it is working: portfolio value up, NAV per share up, cash returns paid, and a pipeline being actioned. In a softer rating environment, the strategy looks sensibly calibrated towards areas where expertise and relationships drive margin.
For retail investors, the investment case remains a blend of NAV growth, ongoing dividends, and potential for further crystallisations. The near-term focus is simple: continued execution by Pantheon, ATC, XPT and others, and careful deployment of that £36.5m cash balance into high-conviction deals.
Related
Keep reading
Investing
Maruwa annual results: sales rise but profits slip as investment surges
Maruwa delivered higher sales and a stronger order book, but lower profit and heavy investment weighed on annual cash flow.
JoshuaJuly 31, 2026
Investing
Wellnex Life Q4 FY26: Cash Flow Positive Again, but Funding Remains Tight
Wellnex Life ended FY26 with stronger revenue, positive quarterly operating cash flow and $862,000 in cash, but financing remains important.
JoshuaJuly 31, 2026
Investing
Ferro-Alloy raises £5.7 million at 25.3% discount to repay Kazakh bonds
Ferro-Alloy has raised £5.7 million at a 25.3% discount, providing funds for bond repayment but creating substantial shareholder dilution.
JoshuaJuly 31, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.